La Universidad y la empresa 3P Biopharmaceuticals potenciarán la investigación y la gestión de talento en tecnología y producción de nuevos medicamentos

La vicerrectora de Investigación de la Universidad de Navarra, Iciar Astiasarán, y el CEO de 3P Biopharmaceuticals, Dámaso Molero, durante la firma del convenio. FOTO: Manuel Castells

Han firmado un convenio para favorecer la transformación digital y la formación de profesionales enfocados a la industria farmacéutica.   La Universidad de Navarra y la empresa 3P Biopharmaceuticals han firmado un convenio para potenciar la formación e investigación en tecnología y producción de nuevos medicamentos, especialmente biotecnológicos. Este acuerdo de colaboración persigue reforzar la figura del farmacéutico […]

Hope for reducing the cardiovascular complications associated with dialysis

Biotech companies Invizius and 3P Biopharmaceuticals collaborate on an innovative technology for patients undergoing hemodialysis and suffering from cardiovascular disease. Invizius, a Scottish biotech company and 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, have initiated a collaboration on an innovative treatment for reducing […]

3P Biopharmaceuticals and SpyBiotech enter into a vaccine contract manufacturing agreement

3P Biopharmaceuticals and SpyBIotech agreement

3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement withSpyBiotech, a company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. Oxford, UK-based SpyBiotech selected 3P Biopharmaceuticals in June 2019 to manufacture a cGMP batch of […]

3P Biopharmaceuticals appoints José Luis Bartolomé as Operational Excellence Director

Professional with extensive experience in biotechnology companies 3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics appoints a new member to the management team with the incorporation of José Luis Bartolomé as Operational Excellence and Continuous Improvement Director. José Luis Bartolomé has a solid […]

3P Biopharmaceuticals appoints Iker Portugal as Chief Financial Officer

3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics incorporates a new member to the management team and appoints Iker Portugal as Chief Financial Officer. Iker Portugal is an experienced financial manager and joins 3P Biopharmaceuticals with the aim of boosting the company´s growth […]

Hope for a new treatment for the autoimmune neuromuscular disease Myasthenia Gravis (MG)

Hope for a new treatment for the autoimmune neuromuscular disease Myasthenia Gravis

3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, together with Toleranzia, a Swedish Biotech company, have initiated a collaboration on innovative treatment for the autoimmune neuromuscular disease Myasthenia Gravis (MG). 3P Biopharmaceuticals and Toleranziabegan their partnership in 2019, when 3P Biopharmaceuticals was selected to […]

3P Biopharmaceuticals renews its “Credit Impôt Recherche” (CIR) by the French Ministry of Higher Education and Research

CIR certificate is extended for a four-year period between 2020-2024 3P Biopharmaceuticals, a European leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has successfully extended its French CIR certificate for another four-year period: 2020-2024. The CIR ”Credit Impôt Recherche” or French Research Tax Credit is a corporate […]

STATEMENT: 3P Biopharmaceuticals shows its commitment against Covid-19

We are living in difficult times due to the COVID19 pandemic, and it is in these times of serious difficulty that 3P Biopharmaceuticals shows its maximum commitment to its employees and to society. Therefore, 3P Biopharmaceuticals makes its capabilities and knowledge available to the Spanish Health Authorities as well as companies in the pharmaceutical and […]

3P Biopharmaceuticals joins International Day of Women and Girls in Science

Day of Women and Girls in Science

At 3P Biopharmaceuticals we celebrate the International Day of Women and Girls in Science, and we want to do so by appreciating and thanking each of the women that forms part of the 3P team. Science and innovation do not understand gender and at 3P Biopharmaceuticals it is a real fact. Out of the 270 […]

Validation batches of the vaccine against equine strangles Strangvac® is completed

vaccine against equine strangles Strangvac

3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics has, together with the Swedish biotechnology company Intervacc AB and LIOF-Pharma (previously Praxis Pharmaceutical), completed the manufacturing process for the vaccine against equine strangles called Strangvac®. The validation production batches required for the forthcoming registration application to the European Medicines […]